
Understanding, Diagnosing, and Using Genetic Testing for PEX7-Related Disorders
Rhizomelic chondrodysplasia punctata and Refsum disease both trace back to PEX7 mutations that disturb peroxisome biogenesis, and both are autosomal recessive.

MD · MBA
Physician specializing in genetic analysis and personalized preventive medicine, and author of Outsmart Your Genes.
Brandon Colby is a physician-expert in the fields of genetic analysis and Personalized Preventive Medicine. He holds an MD from the Mount Sinai School of Medicine, an MBA from Stanford University's Graduate School of Business, and a degree in Genetics from the University of Michigan.
Dr. Colby is the author of the book Outsmart Your Genes and has developed numerous technologies that improve the analysis, interpretation, and actionability of genome sequencing data. He is an Affiliate Specialist of the American College of Medical Genetics and Genomics (ACMG), an Associate of the American College of Preventive Medicine (ACPM), and a member of the National Society of Genetic Counselors (NSGC).
Articles by Brandon Colby, MD are reviewed for accuracy by Sequencing's medical and scientific team. This page is for informational purposes and does not constitute medical advice.

Rhizomelic chondrodysplasia punctata and Refsum disease both trace back to PEX7 mutations that disturb peroxisome biogenesis, and both are autosomal recessive.

Facial abnormalities, developmental delays and immune dysfunction appear across POLR1C-related disorders, which include Treacher Collins syndrome and leukodystrophies.

Mutations in POMGNT1 underlie muscle-eye-brain disease, Walker-Warburg syndrome and LGMD2O, with muscle weakness, intellectual disability and eye abnormalities.

Two copies of a mutated gene, one from each parent, cause MCPH; growth charts, MRI and DNA testing confirm it, and carrier or prenatal testing is open to families.

Alzheimer's, Parkinson's and Huntington's disease and ALS all involve gradual neuron loss; APP, PSEN1, PSEN2 and HTT results can confirm inherited forms.

Faulty peripherin-2 destabilizes photoreceptors, causing retinitis pigmentosa, macular, pattern or cone-rod dystrophy; ERG, OCT and gene testing confirm the diagnosis.

SFTPC mutations disturb surfactant protein C, leaving rapid breathing, wheezing and recurrent infections; blood testing confirms the subtype and supports carrier checks.

SFTPB, SFTPC, ABCA3 and NKX2-1 mutations can leave a newborn in respiratory distress, and testing supports carrier screening, prenatal diagnosis and PGD before IVF.